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Tracking down biotransformation to the genetic level: hydroxylation, isomerization and glycosylation [1] [2] [3] . Detection of the enzymes catalyzing the 30 biotransformation reactions is of great interest since the use of these enzymes as a tool for the 31 synthesis of modified drug leads allows to economically generate desired products. 32
Many natural products are decorated with carbohydrates essential for the interaction with their 33 biological targets. Particularly deoxyhexoses are important carbohydrate components which 34 mediate biological activity of the glycoconjugates. They often play a key role as recognition 35 elements in the mechanism of action of respective bioactive compounds 4 . Adding or 36 exchanging sugars can dramatically improve the pharmacological properties of a compound 37 and change the molecular mechanism of its mode of action [5] [6] [7] . As a result of the potential to 38 alter these properties there is intense interest in efficient methods to glycosylate small 39 molecules and thus develop improved therapeutic agents. As chemical synthesis of 40 glycosylated compounds is challenging and expensive 8,9 the use of glycosyltransferases to 41 perform glycosylation is an effective and economical alternative. Several in vitro and in vivo 42 strategies have been employed to glycosylate a given compound. However, these approaches 43 are limited by the high substrate specificity of glycosyltransferases 10, 11 . Until now, only a few 44 enzymes are known to glycosylate different acceptor substrates 12 . Consequently, new 45 glycosyltransferases with low substrate specificity are urgently needed. 46
Strains of the genus Saccharothrix, which is a member of the order Actinomycetales, are 47 6 Structure elucidation. Nuclear Magnetic Resonance spectra (NMR) of alipro2, alic1, alipro4 130 and aliproN were measured on a Varian VNMR-S 600MHz spectrometer equipped with 3mm 131 triple resonance inverse and 3 mm dual broadband probes. Pulse sequences were taken from 132
Varian pulse sequence library. These spectra are recorded in 150µl DMSO-d 6 at T = 35°C. 133 NMR spectra of alipro1, emopro1, emopro2, emopro3, ant14pro1, quercpro1, novpro1, 134 novpro3 and novpro5 were measured on a Bruker Avance DRX 400 spectrometer equipped 135 with a 5 mm broadband probe and were recorded in 550µl DMSO-d 6 at room temperature 136 (around 22 °C). Pulse sequences were taken from Bruker pulse sequence library. The NOESY 137 spectrum of alipro1 was recorded on a JEOL ECX400 spectrometer, equipped with a 5 mm 138 broadband probe, and were recorded in 600µl DMSO-d 6 at 40 °C. Solvent signals were used 139 as internal standard (DMSO-d 6 :  H = 2.5,  C = 39.5 ppm). For alipro1, emopro1, emopro2, 140 emopro3, ant14pro1, quercpro1, novpro1, novpro3 and novpro5 high-resolution electron 141 spray ionization mass spectra (HR-ESI-MS) were measured on a LTQ Orbitrap (Thermo 142 was diversified for the determination of the pH which leads to the highest amount of alipro1. 177
To identify the optimal pH and incubation temperature for the production of alipro1, the 
Gene deletion, complementation and heterologous expression experiments 228
In an effort to delineate the promiscuous rhamnosyltransferase/s gene deletion and gene 229 expression experiments have been performed. Gene inactivation experiments were carried out 230 with genes encoding glycosyltransferases belonging to CAZy family 1 which are located 231 10 beyond the saccharomicin gene cluster. Mutants with deletions in ses44520, ses45900, 232 ses47640 and ses49200 were still able to rhamnosylate alizarin, while S. espanaensis with a 233 mutation in ses60310 was not able to perform the glycosylation reaction. Figure 3 II shows 234 that the inactivation mutant S. espanaensis Δses60310 was not able to glycosylate alizarin. 235
Nevertheless, biotransformation products were observed for the feeding of this mutant. 236
Alipro3 und alipro4, the 3-hydroxylated and the 2-methoxylated and 3-hydroxylated 237 derivatives of alizarin respectively, were detected. Additionally, S. espanaensis Δses60310 238 also did not convert emodin, quercetin and novobiocic acid to rhamnosylated 239 biotransformation products indicating that Ses60310 is the glycosyltransferase responsible for 240 promiscuous glycosylation in S. espanaensis (data not shown). This is also supported by the 241 results for the feeding of S. espanaensis Δses60310 x pSET-ses60310 with alizarin. As shown 242
in Figure 3 
Purification and in vitro characterization of Ses60310 268
The gene ses60310 was heterologously expressed in an E. coli strain coexpressing 269 streptomyces chaperonins 17, 20 . Thereby, soluble protein was produced that was purified to 270 homogeneity. The protein Ses60310 was subsequently deployed in an in vitro assay. The 271 enzyme catalysed the reaction of alizarin and dTDP-L-rhamnose to alipro1 and dTDP. At 272 pH 8.8 and 37 °C incubation temperature the production of alipro1 reached its peak value. 273
The enzymatic parameters of this reaction were approximated to K m (alizarin) 31 µM and 274 v max (alizarin) 0.0015 s -1 . 275
The bioactivity of glycosylated natural products synthesized by actinomycetes can often be 277 attributed to their saccharide moiety. Recently, glycodiversification studies, with the overall 278 goal of generating novel compounds with altered activities or improved properties, have 279 attracted a lot of attention. 280
Glycosyltransferases, which catalyze the attachment of a sugar moiety to an aglycon, are key 281 enzymes for glycodiversification. Some natural product glycosyltransferases are sufficiently 282 12 promiscuous for the use in altering the glycosylation patterns but most of them show strict 283 substrate specificity which is a limiting factor in natural product diversification. Examples for 284 flexible glycosyltransferases are listed in Table 3 . Most flexible glycosyltransferases show 285 flexibility towards the sugar donor but only a few glycoyltransferases including OleD and 286
OleI exhibit remarkable aglycon promiscuity. In order to find glycosyltransferases with broad 287 substrate specificity we got interested in Saccharothrix espanaensis. We observed that 288 phenolic compounds fed to the strain were converted to modified compounds with high 289 conversion rates. Structure elucidation revealed mono-and dirhamnosylated derivatives. The 290 acceptor spectrum included a diverse range of "drug-like" structures, such as anthraquinones, 291 a flavonoid, and an aminocoumarin derivative. 292
The desired glycosyltransferase gene (genes) was (were) expected to be similar to flexible 293 glycosyltransferases involved in natural product glycosylation or to enzymes which transfer 294 rhamnose to a phenolic compound. In the genome of S. espanaensis 20 suitable 295 glycosyltransferase genes were identified. Among these candidates Ses60310 was detected to 296 be responsible for the rhamnosylation of the compounds used in our studies. 297
The glycosyltransferase Ses60310 uses different nucleotide activated sugars, accepts different 298 aglyca and has a remarkable regioflexibility. The gene ses60310 is not part of one of the 26 299 secondary metabolite gene clusters in the genome of S. espanaensis 14 . Therefore, it is 300 reasonable that Ses60310 is not involved in natural product biosynthesis but might be 301 involved in a defense mechanism protecting the strain by glycosylating natural products 302 entering the cell, comparable to OleD and OleI. Hence, this kind of xenobiotica glycosylating 303 enzymes seems to be much more suitable for glycodiversification than biosynthetic enzymes. 304
Since we proved that Ses60310 has some sugar flexibility and accepts a variety of phenolic 305 compounds as substrates, we identified a valuable enzyme for further studies. 
